Skip to main content

OptimizeRx Corp 10-Q for FY2026 Q3

OptimizeRx Corp (OPRX)

10-Q 2026-11-13 For: 2026-09-30
View Original
Added on November 14, 2026

About this 10-Q

OptimizeRx Corp filed this 10-Q on November 13, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

OptimizeRx reported a 20% revenue decline and a $(3) net loss for the nine months ended September 30, 2026, versus $112 net income in 2025. Disclosure controls also remained ineffective due to a material weakness. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$21.62M
down 17.1% from $26.07M a year earlier
Net income
$1.2M
up 53.4% from net income of $779K a year earlier
Diluted EPS
$0.06
up 50.0% from $0.04 a year earlier